PTC Therapeutics Inc.

NASDAQ: PTCT · Real-Time Price · USD
48.82
0.12 (0.25%)
At close: Aug 15, 2025, 3:59 PM
48.92
0.20%
After-hours: Aug 15, 2025, 07:52 PM EDT

PTC Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
779.71M 594M 279.83M 189.72M
Short-Term Investments
359.99M 282.74M 130.87M 583.66M
Long-Term Investments
n/a 16.28M 16.09M 7.5M
Other Long-Term Assets
20.7M 19.96M 48.58M 227.49M
Receivables
158.55M 161.02M 155.61M 110.45M
Inventory
23.19M 30.58M 21.81M 15.86M
Other Current Assets
44.09M 150.29M 105.66M n/a
Total Current Assets
1.37B 1.22B 693.78M 954.37M
Property-Plant & Equipment
117.66M 178.99M 175.02M 130.01M
Goodwill & Intangibles
201.13M 461.84M 788.23M 807.18M
Total Long-Term Assets
339.49M 677.07M 1.01B 1.16B
Total Assets
1.71B 1.9B 1.71B 1.94B
Account Payables
17.27M 6.04M 27.27M 23.03M
Deferred Revenue
5.5M 801K 1.35M 265.75M
Short-Term Debt
257.82M 194.31M 72.15M 208.83M
Other Current Liabilities
271.29M 139.82M 225.72M -55.56M
Total Current Liabilities
580.98M 603.1M 406.24M 509.35M
Long-Term Debt
2.11B 1.9B 1.26B 956.59M
Other Long-Term Liabilities
22.23M 36.44M 166.64M 377.01M
Total Long-Term Liabilities
2.22B 2.11B 1.65B 1.43B
Total Liabilities
2.8B 2.71B 2.05B 1.94B
Total Debt
2.47B 2.23B 1.46B 1.27B
Common Stock
77K 75K 72K 71K
Retained Earnings
-3.65B -3.28B -2.66B -2.1B
Comprehensive Income
-25.89M -1.28M 4.8M -24.28M
Shareholders Equity
-1.1B -818.55M -347.09M 1.44M
Total Investments
359.99M 282.74M 130.87M 591.16M